Sarcoplasmic reticulum calcium defect in Ras-induced hypertrophic cardiomyopathy heart.
about
A mouse model for Costello syndrome reveals an Ang II-mediated hypertensive conditionScaffold Proteins Regulating Extracellular Regulated Kinase Function in Cardiac Hypertrophy and DiseaseGene and cell therapies for the failing heart to prevent sudden arrhythmic deathSmall G proteins in the cardiovascular system: physiological and pathological aspectsFibroblast growth factor receptor 1 signaling in adult cardiomyocytes increases contractility and results in a hypertrophic cardiomyopathyMitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humansOral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunctionGender differences in the modulation of cardiac gene expression by dietary conjugated linoleic acid isomersThe ral exchange factor rgl2 promotes cardiomyocyte survival and inhibits cardiac fibrosisActivation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy.Stiffness- and relaxation-based quantitation of radial left ventricular oscillations: elucidation of regional diastolic function mechanisms.Statins and myocardial remodelling: cell and molecular pathways.Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectivesMEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutationCapacity for resolution of Ras-MAPK-initiated early pathogenic myocardial hypertrophy modeled in mice.Cyclosporine attenuates cardiomyocyte hypertrophy induced by RAF1 mutants in Noonan and LEOPARD syndromes.SR calcium handling dysfunction, stress-response signaling pathways, and atrial fibrillation.Human Engineered Cardiac Tissues Created Using Induced Pluripotent Stem Cells Reveal Functional Characteristics of BRAF-Mediated Hypertrophic Cardiomyopathy.Quantitative analysis of the chromatin proteome in disease reveals remodeling principles and identifies high mobility group protein B2 as a regulator of hypertrophic growth.The Ca2+ ATPase of cardiac sarcoplasmic reticulum: Physiological role and relevance to diseasesPhosphodiesterase 4D and heart failure: a cautionary tale.Mitogen-activated protein kinases in heart development and diseasesRegulator of G protein signalling 14 attenuates cardiac remodelling through the MEK-ERK1/2 signalling pathway.Effects of thapsigargin and phenylephrine on calcineurin and protein kinase C signaling functions in cardiac myocytes.Autonomous and Non-autonomous Defects Underlie Hypertrophic Cardiomyopathy in BRAF-Mutant hiPSC-Derived Cardiomyocytes.Cdc42 is an antihypertrophic molecular switch in the mouse heart.Signaling to cardiac hypertrophy: insights from human and mouse RASopathies.Key role of ERK1/2 molecular scaffolds in heart pathology.The Stress-Response MAP Kinase Signaling in Cardiac Arrhythmias.Murine Electrophysiological Models of Cardiac Arrhythmogenesis.H-Ras Isoform Mediates Protection Against Pressure Overload-Induced Cardiac Dysfunction in Part Through Activation of AKT.Cellular interplay via cytokine hierarchy causes pathological cardiac hypertrophy in RAF1-mutant Noonan syndrome.Protein disulfide isomerase increases in myocardial endothelial cells in mice exposed to chronic hypoxia: a stimulatory role in angiogenesis.Phenylephrine hypertrophy, Ca2+-ATPase (SERCA2), and Ca2+ signaling in neonatal rat cardiac myocytes.Pin1 facilitates isoproterenol‑induced cardiac fibrosis and collagen deposition by promoting oxidative stress and activating the MEK1/2‑ERK1/2 signal transduction pathway in rats.Inhibition of mevalonate pathway prevents ischemia-induced cardiac dysfunction in rats via RhoA-independent signaling pathway.Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome: a Ras/MAPK pathway syndrome.Network-based predictions of in vivo cardiac hypertrophyDistinct gene expression profiles in adult mouse heart following targeted MAP kinase activation
P2860
Q24655745-57FC9244-7B83-4D1D-BEB5-5C0FBFD00C94Q26765993-8249948E-2725-49AA-BC1B-214C3B2A7BDBQ26865425-AA97B4AA-F316-41FB-8EC5-32DD624FEB7DQ27010607-1432AA3A-8994-41F5-9A52-F4EC0704445AQ27342077-AE29953D-0FFB-4BC5-A2A5-242C945852A3Q28296128-3932B6C9-2D4F-4A8C-9959-8246BEA2B178Q28302847-D65C058C-84DA-4159-BF81-37C4BDDB36E7Q28569684-D1E50CDE-03A4-4D07-B602-460F2F993765Q28580083-24142452-AC3B-4376-80B1-703BCFEA5B53Q28594924-1177B3D5-A98C-446A-B49D-0A784A8D8E80Q30498939-DB64467E-E60C-4C75-900E-3C467D34DFEDQ33270439-326DE6B4-2385-42AF-A591-A0F0BA0A81DCQ34196628-405CFBE3-D1EB-4CAB-8F1F-E2469899E072Q34289211-35AD5430-975B-4E2C-B0EE-B57B9E654F8CQ34627221-9DF72C26-42C1-4FAD-A30B-9B8B10AE2656Q34819898-D04E3A04-F12E-4191-99C7-70BF6EBB55EAQ35011843-37395224-82B4-4548-9888-15B538012237Q35099320-EE076501-1661-4F2E-8DBC-FE8F1850F64BQ35897783-FC1ED31D-8243-491D-BF63-A87C04A12CDEQ36208949-B11F630B-9497-4C53-808C-16CB564DC8ECQ36570908-74CA1D92-7F69-4A18-A299-68DABAFE083CQ36596672-C46EA4DD-EE88-4B46-8C70-A5A525118102Q36944485-FB5806E3-86DE-4EC9-A042-89585C29E893Q36999880-6E4A869C-5876-4B2B-80DE-D6A42A34D941Q37190351-AA3F8F4E-261A-49CB-B3BE-AE73010E674DQ37274416-3E986AE9-B3DE-412B-B38F-709C9995731EQ37363031-076E1F1A-7596-448B-A8A5-1EB1B95CF6D5Q38009216-1754B996-8696-42A3-8F8F-08D42C8A0A3EQ38093445-36563B13-C856-4FFD-8DD4-C00B8D20D433Q38795069-3E2D85B9-4815-4339-BB81-4C396B32C0CBQ39038606-F727214A-A80C-4FDD-99E6-BEDFBF610FFAQ40337583-7FF7C637-EDB1-4ECA-9B7E-1E793EDB0A57Q41976316-F7826B99-A703-40D6-9850-686DF2DECDDBQ44635832-FDEF6A72-B80F-40B3-8C83-7F829275E2DBQ46647997-29424E72-53B2-49C8-A248-2D1633891116Q47246498-AEB7C53E-8A02-49B9-96E4-6D6A75BD032FQ48194283-1EA1F17F-12C3-4865-9D59-596190CB8E51Q54610891-6D048E30-ED6A-45C5-93CF-D5FE4BB42EE9Q56335220-75C984D4-6A34-4271-B58F-B16B01A7CDBCQ58198513-E0CF9ECF-845B-4CD7-8D23-09A63600F6E0
P2860
Sarcoplasmic reticulum calcium defect in Ras-induced hypertrophic cardiomyopathy heart.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Sarcoplasmic reticulum calcium defect in Ras-induced hypertrophic cardiomyopathy heart.
@en
Sarcoplasmic reticulum calcium defect in Ras-induced hypertrophic cardiomyopathy heart.
@nl
type
label
Sarcoplasmic reticulum calcium defect in Ras-induced hypertrophic cardiomyopathy heart.
@en
Sarcoplasmic reticulum calcium defect in Ras-induced hypertrophic cardiomyopathy heart.
@nl
prefLabel
Sarcoplasmic reticulum calcium defect in Ras-induced hypertrophic cardiomyopathy heart.
@en
Sarcoplasmic reticulum calcium defect in Ras-induced hypertrophic cardiomyopathy heart.
@nl
P2093
P2860
P1476
Sarcoplasmic reticulum calcium defect in Ras-induced hypertrophic cardiomyopathy heart.
@en
P2093
Jader Dos Santos Cruz
Jeanine A Ursitti
Jonathan W Lederer
Keith Dilly
Kenneth R Chien
Manxiang Li
Meizi Zheng
P2860
P304
P356
10.1152/AJPHEART.00110.2003
P50
P577
2003-09-11T00:00:00Z